Phase I, Open-Label, Randomized, 3-Way Crossover Trial to Assess the Pharmacokinetics of Darunavir (DRV) Given Once-Daily With Different Doses of Ritonavir in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Darunavir; Darunavir; Ritonavir; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 29 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jan 2009 Planned number of patients changed from 18 to 21 as reported by ClinicalTrials.gov.